« Back
Home /
CD5L Blocking Peptide (N-term)

CD5L Blocking Peptide (N-term)

Item no.	ABC-BP19894a
Manufacturer	Abcepta
Amount	500 ug
Category	Oncology By Cell Type Hematology Leukemia Lymphoma Peptides & Proteins Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010): Davila, S., et al. Genes Immun. 11(3):232-238(2010) Chapuis, J., et al. Mol. Psychiatry 14(11):1004-1016(2009) Qu, P., et al. J. Immunol. 182(3):1648-1659(2009) Kim, W.K., et al. Exp. Mol. Med. 40(6):677-685(2008)
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	CD5 antigen-like,CT-2,IgM-associated peptide,SP-alpha,CD5L,API6
Similar products	CD5L, API6, CD5 antigen-like, CT-2, IgM-associated peptide, SP-alpha
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence is selected from aa 79-93 of HUMAN CD5L
Bio Background	CD5L may play a role in the regulation of the immune system. Seems to play a role as an inhibitor of apoptosis.
Gene Name	CD5L
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP19894a-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 13 days

Compare

Add to wishlist

Get an offer